NutriStack
Cannabis (THC-Dominant) and Olanzapine, a conflict.
THC-dominant cannabis can undermine olanzapine treatment by increasing relapse risk and worsening psychosis outcomes. Systematic reviews link continued cannabis use in psychosis with more relapse, poorer adherence, and antipsychotic treatment failure. The combination can also add impairment and sleepiness in people already sensitive to olanzapine sedation.
One pair, every claim cited. The two substances, the type, the mechanism, the recommendation, and the primary literature.
Same shape as the other 1,729 pairs in the public database.
From the interaction database
What the row says.
Every entry follows the same shape: what is happening, the mechanism, the recommendation, and the primary literature.
At a glance
- Substances
- Cannabis (THC-Dominant) and Olanzapine
- Pair type
- Conflict
- Evidence (highest tier)
- Strong
- Source citations
- 2 sources
- Stack Score effect
- −10 to your Stack Score (per scored conflict row).
- Scope
- Supplement × Prescription
- Last verified
- May 30, 2026
Conflict · Strong evidence
Conflict
What is happening. THC-dominant cannabis can undermine olanzapine treatment by increasing relapse risk and worsening psychosis outcomes. Systematic reviews link continued cannabis use in psychosis with more relapse, poorer adherence, and antipsychotic treatment failure. The combination can also add impairment and sleepiness in people already sensitive to olanzapine sedation.
Mechanism. THC can worsen psychotic symptoms through CB1-mediated changes in dopamine and glutamate signaling. Olanzapine reduces relapse risk through D2 and 5-HT2A antagonism, while continued cannabis exposure and cannabis-related nonadherence push in the opposite direction.
Recommendation. Avoid THC-dominant cannabis while taking olanzapine for psychosis or mood stabilization. If cannabis use continues, your prescriber should know so relapse risk, adherence, and sedation can be monitored. Dose timing separation is not a reliable safety strategy.
Sources (2)
- Zammit S, Moore TH, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, et al. Effects of cannabis use on outcomes of psychotic disorders: systematic review. Br J Psychiatry. 2008;193(5):357-363. PMID 18978312
- Schoeler T, Monk A, Sami MB, Klamerus E, Foglia E, Brown R, et al. Continued versus discontinued cannabis use in patients with psychosis: a systematic review and meta-analysis. Lancet Psychiatry. 2016;3(3):215-225. PMID 26777297
Stack Score
How this pair moves the number.
Effect on the composite score
If both Cannabis (THC-Dominant) and Olanzapine are in the same stack, this pair applies −10 to your Stack Score (per scored conflict row).
The full algorithm, the clamping rules, and four worked stacks are documented at /methodology/stack-score.
Check your full routine
One pair was the worked example. NutriStack runs every pair in your stack at once.
Drop in your supplements and prescriptions and the public database surfaces every interaction, synergy, timing rule, and contraindication, every one linked to its primary source.